MCRB icon

Seres Therapeutics

69 hedge funds and large institutions have $52.5M invested in Seres Therapeutics in 2024 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

9% less funds holding

Funds holding: 7669 (-7)

12% less capital invested

Capital invested by funds: $60M → $52.5M (-$7.49M)

44% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 16

Holders
69
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.75M
Puts
$287K
Net Calls
Net Calls Change

Top Sellers

1 -$869K
2 -$719K
3 -$277K
4
TCM
Tang Capital Management
California
-$189K
5
Citigroup
Citigroup
New York
-$178K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$19.3M
2
$18.1M
3
$4.88M
4
$1.67M
5
$1.5M
6
$1.46M
7
$1.26M
8
$780K
9
$720K
10
$416K
11
$284K
12
$283K
13
$272K
14
$218K
15
$208K
16
$94K
17
$83.7K
18
$79.6K
19
$78.8K
20
$70.6K
21
$59.1K
22
$58.2K
23
$51.5K
24
$48.8K
25
$44K